Skip to content
OpenSampling

2019 · BMC infectious diseases · open access

Comparative study of OMNIgene®•SPUTUM reagent versus cold-chain for the transportation of sputum samples to GeneXpert®MTB/RIF testing sites in Malawi

Alemayehu et al.

The finding, in our words

OMNIgene SPUTUM treated sputum specimens stored and transported at ambient temperature for up to 29 days yielded GeneXpert MTB/RIF results comparable to cold chain samples, with very good inter test agreement (kappa 0.97) and 99% overall agreement, supporting decentralised testing without cold chain.

A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.

Labels

  1. 2024

    Omnigene-Gut<sup>tm</sup> ensures fecal microbiome stability in the pediatric population

    In children, stool preserved in OMNIgene-GUT kept its microbial community structure better than unpreserved stool, with alpha and beta diversity similar to direct freezing, which supports the kit for decentralised stool collection from children.

    Hoogendijk et al., AMB Express · source ↗

    • dct
    • stabilised
    • dna-genotek-omnigene
    • microbiome
    • pediatric
    • stool
    • validation
  2. 2023

    Diagnostic accuracy of Xpert MTB/RIF Ultra and culture assays to detect Mycobacterium Tuberculosis using OMNIgene-sputum processed stool among adult TB presumptive patients in Uganda

    Processing stool samples with OMNIgene SPUTUM significantly improved the diagnostic yield of Mycobacterium tuberculosis using the Xpert MTB/RIF Ultra assay compared to standard methods, offering a viable alternative for patients who cannot produce sputum.

    Sessolo et al., PloS one · source ↗

    • stabilised
    • dna-genotek-omnigene
    • serology
    • stool
    • validation
  3. 2022

    High Mycobacterium tuberculosis Bacillary Loads Detected by Tuberculosis Molecular Bacterial Load Assay in Patient Stool: a Potential Alternative for Nonsputum Diagnosis and Treatment Response Monitoring of Tuberculosis

    TB-MBLA testing of OMNIgene-stabilised stool detected Mycobacterium tuberculosis with 80% sensitivity and 79% specificity against sputum culture in 100 adults, offering a viable alternative for patients unable to produce sputum. The RNA-based assay quantified bacterial load, showing higher burdens in HIV-co-infected individuals, while stool cultures suffered 21-26% contamination rates.

    Musisi et al., Microbiology spectrum · source ↗

    • stool
    • stabilised
    • dna-genotek-omnigene
    • validation
    • serology
  4. 2021

    Standardized preservation, extraction and quantification techniques for detection of fecal SARS-CoV-2 RNA

    The paper identified that the Zymo DNA/RNA shield preservative paired with the QIAamp Viral RNA Mini Kit extraction yielded more detectable SARS-CoV-2 RNA from stool than the OMNIgene-GUT kit or storage without preservative. This supports decentralised diagnostics by establishing a validated method for preserving and analysing self-collected stool samples, enabling reliable detection of viral shedding for epidemiology and patient management.

    Natarajan et al., Nature communications · source ↗

    • stool
    • stabilised
    • dna-genotek-omnigene
    • validation
    • serology
  5. 2017

    Detection of Plasmodium falciparum DNA in saliva samples stored at room temperature: potential for a non-invasive saliva-based diagnostic test for malaria

    This study found that saliva collected with the OMNIgene ORAL kit and stored at room temperature for up to 13 months allowed for the detection of Plasmodium falciparum DNA with high sensitivity and specificity compared to blood tests, suggesting it is a viable non-invasive alternative for malaria diagnosis.

    Mfuh et al., Malaria journal · source ↗

    • stabilised
    • dna-genotek-omnigene
    • serology
    • validation
    • saliva